China’s Clover raises $230 mln, plans vaccines for COVID-19 variants
China’s Clover Biopharmaceuticals, a developer of coronavirus vaccines, has raised $230 million from investors, including Singapore’s state investment firm Temasek Holdings [TEM.UL], it said on …